Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
Dr. Mahdavi will lead Ginkgo's commercial efforts in the growing areas of bio-reagents, cell and gene therapies and new biopharmaceutical modalities.
Bora establishes a leadership position in Taiwan's CDMO sector as it continues to expand into the global CDMO market
Under the agreement, Porton Advanced will provide services to accelerate the development, production and registration of breakthrough cell therapies currently being developed by Sinorda Biomedicine
The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets
The Blockchain-based solution was awarded the 2021 Bionow Technical Service Award
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
Subscribe To Our Newsletter & Stay Updated
